Skip to main content
Research article - Peer-reviewed, 2013

Longitudinal Analysis of Quality of Life, Clinical, Radiographic, Echocardiographic, and Laboratory Variables in Dogs with Myxomatous Mitral Valve Disease Receiving Pimobendan or Benazepril: The QUEST Study

Häggström, Jens; Boswood, A.; O'Grady, Michael; Jöns, O.; Smith, S.; Swift, S.; Borgarelli, Michele; Gavaghan, Brad; Kvart, Clarence; DiFruscia, Rocky


Conclusions and Clinical ImportancePimobendan versus benazepril resulted in similar QoL during the study, but conferred increased time before intensification of CHF treatment. Pimobendan treatment resulted in smaller heart size, higher body temperature, and less retention of free water.


Canine; Mitral regurgitation; Mortality; Therapy

Published in

Journal of Veterinary Internal Medicine
2013, volume: 27, number: 6, pages: 1441-1451

Authors' information

Swedish University of Agricultural Sciences, Department of Clinical Sciences
Boswood, A.
Royal Veterinary College
O'Grady, Michael
Jöns, O.
Boehringer Ingelheim Vetmedica GmbH
Smith, S.
Scarsdale Veterinary Hospital
Swift, S.
Northwest Surgeons
Borgarelli, Michele
Gavaghan, Brad
Swedish University of Agricultural Sciences, Department of Anatomy, Physiology and Biochemistry (AFB)
DiFruscia, Rocky

UKÄ Subject classification

Other Veterinary Science

Publication Identifiers


URI (permanent link to this page)